Validation of MMS Test for Cancer Monitoring

NCT ID: NCT02113683

Last Updated: 2018-06-21

Basic Information

• Recruitment Status: TERMINATED
• Total Enrollment: 100 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2014-05-31
• Study Completion Date: 2018-06-20

Brief Summary

The purpose of this study is the validation of MMS test to detect active tumor growth in different cancer types before and after therapy, as well as in the course of therapy and for subsequent relapse control compared to standard methods (clinical examination, imaging, tumor markers). It should be consider whether the MMS test has comparable diagnostic accuracy, and thus can replace more expensive or invasive procedures in future.

Conditions

Colo-rectal Cancer; Stomach Cancer; Melanoma; Sarcoma

Study Design

• Observational Model Type: CASE_ONLY
• Study Time Perspective: PROSPECTIVE

Study Groups

MMS test

therapy monitoring of patients with colo-rectal or stomach disease or with melanoma

No interventions assigned to this group

Eligibility Criteria

Inclusion Criteria

• Clinical diagnosis of colo-rectal cancer
• Clinical diagnosis of stomach cancer
• Suspected diagnosis of melanoma

Exclusion Criteria

• Colitis ulcerosa
• Morbus Crohn
• Cancer in time period two years before
• Cancer therapy in time period two years before

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Helios Klinikum Berlin-Buch

OTHER

Sponsor Role: collaborator

MedInnovation GmbH

INDUSTRY

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Katja Waterstradt, PhD

Role: PRINCIPAL_INVESTIGATOR

MedInnovation GmbH

Locations

HELIOS Klinikum Berlin-Buch, Klinik für Interdisziplinäre Onkologie

Berlin, , Germany

Countries

Germany

Other Identifiers

MMS-tm14

Identifier Type: -

Identifier Source: org_study_id